POSTERS ASCO 2024

Cáncer de mama

Local, regional y adyuvante

Fulvestrant with or without the cyclin-dependent kinase 7 (CDK7) inhibitor samuraciclib in advanced hormone receptor positive (HR+) breast cancer after CDK4/6 inhibition: Phase II SUMIT-BC study.

Fulvestrant with or without the cyclin-dependent kinase 7 (CDK7) inhibitor samuraciclib in advanced hormone receptor positive (HR+) breast cancer after CDK4/6 inhibition: Phase II SUMIT-BC study.

Abstract: TPS1126 Poster Bd #: 101a

Poster

Descargar

Autor
Sonia Pernas, MD, PhD

Institut Català d'Oncologia, IDIBELL, L’Hospitalet

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON